Home / About us / Leadership / Chris Rice, BSc
Chris Rice, BSc
Senior Quality Assurance Manager
Chris earned a Bachelor of Science in Biology/Chemistry from Mount Allison University and has extensive experience in oncology drug development, including a tenure as a Senior Scientist. His scientific background offers a valuable perspective that bridges research, quality, and regulatory functions, enabling him to effectively support laboratory, project, and leadership teams in achieving high-quality research results.
As Senior Quality Assurance Manager, Chris manages the company’s Quality Management System (QMS) and drives quality, regulatory compliance, and data integrity across preclinical and clinical research operations. He provides strategic oversight of document control, quality events, audit and inspection programs, training, supplier qualification and assessments, equipment qualification, and computerized system validation (CSV), ensuring that quality systems remain effective, compliant, and inspection-ready.
Through risk-based decision-making and a commitment to continuous improvement, Chris strengthens quality processes, optimizes QMS systems, and provides expert guidance on regulatory requirements to support reliable, compliant research operations for AGADA and its clients.
Get in touch
To learn how AGADA Biosciences could support your program, get in touch with our team and start the conversation.
How we work
We bring an agile, collaborative and responsive approach to every engagement, shaping our support around the needs of your program rather than a rigid process. Whether you engage us at a single stage or across multiple points in development, we work to de-risk programs, protect data integrity and help your teams progress with confidence.
1
Refined for your program:
We shape our approach around the needs of each program, not the other way around.
2
Direct access to senior experts:
Our lean model keeps scientific expertise close to the work and communication clear.
3
Built to de-risk progress:
We help you de-risk development through rigorous science and practical support.
4
Protecting data integrity:
Our work is designed to support reliable outputs and maintain confidence in the data.
Why AGADA?
We bring dedicated expertise to programs where there is little room for error, providing the scientific support, responsiveness and program fit that help rare disease teams move forward with clarity.
Decade of specialization:
Founded in 2013 as a spinout from Children’s National Medical Center to provide specialist scientific support for rare disease drug development.
Consistent audit success:
We successfully pass an average of five sponsor audits annually to support clinical trials across multiple phases.
Historical benchmarking:
We leverage archival data from over 100 trials in mouse models of muscular dystrophy to accurately power your efficacy studies.
Dedicated scale:
We operate with a team of approximately 50 employees, entirely focused on executing complex rare disease programs.
Meet more of the leadership team
